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This focus issue assembles publications on the issues presented and discussed at the two-day 
international conference “Human Biomonitoring: Political benefits – scientific challenges” 
held in Berlin on September 26–28, 2010. The major aim of this conference was to bring 
together the broad variety of human biomonitoring (HBM) activities conducted worldwide 
to present a clear picture of HBM's use in science and regulation. The conference was jointly 
organized by the German Federal Ministry for the Environment, Nature Conservation and 
Nuclear Safety (BMU) and the German Federal Environment Agency (UBA) to elucidate 
and describe the scientific challenges as well as the political benefits of HBM. The global 
dimension of HBM was illustrated by contributions from HBM activities in Asia, Africa, 
North and South America, and Europe, and the participation of experts from 36 countries.
HBM studies investigate human exposure to environmental chemicals and their potentially 
harmful impacts on public health. HBM informs environment and health policy by providing 
scientific data on: (a) which substances are absorbed by the human body, (b) the exposure 
levels, (c) whether certain groups of the population are particularly affected, and (d) whether 
chemical policy regulations have led to the intended decrease in exposure. Based on these 
assumptions the conference participants were invited to:
• examine the strengths and limitations of HBM in the detection and assessment of 
human exposures,
• take a critical look at which substances should be examined as a matter of priority 
and the health impacts that may be expected from chemical exposure, and
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• discuss the incorporation of HBM into national and international initiatives on 
environmental health.
The conference opened with a discussion by a panel of stake-holders on the strengths and 
limitations of HBM. The scientific conference agenda consisted of five sessions: (1) lessons 
learned from existing programs; (2) future challenges and emerging programs; (3) HBM and 
health effects; (4) risk assessment of HBM data; and (5) going global – Do we need global 
HBM? The conference concluded with a panel discussion on the political dimension of 
HBM.
Expert speakers from nearly all parts of the world confirmed, with their extensive studies, 
that HBM is a useful tool for detecting human exposure to industrial chemicals, as well as to 
natural substances. The conference demonstrated the significant growth in knowledge of 
environmental chemical exposure in humans and the related health impacts. This growing 
knowledge requires scientists and regulators from all over the world to address public 
concerns and to take appropriate actions.
Chemical priorities for HBM vary from country-to-country and region-to-region due to 
differences in current chemical usage, exposure levels and regulation status. For example, in 
Europe the focus has changed from substances such as lead and cadmium to second- and 
third-generation plasticizers and flame retardants. In Asia and Africa, the emphasis is 
currently on substances including dichlorodiphenyltrichloroethane (DDT), polychlorinated 
biphenyls (PCBs) and lead, many of which have long been banned or are subject to severe 
use restrictions in Europe, North America and elsewhere. Thus, HBM data show that some 
products remain in use in certain countries despite having been banned in others. Some of 
these substances may be present due to their persistence in the environment and global 
distribution. As new substances are constantly being introduced, there is a need to expand 
the range of substances that can be measured by HBM to keep pace with chemical product 
innovation. Development of new analytical methods for emerging substances and their 
inclusion in future HBM studies is one of the challenges ahead. Establishing specimen 
biobanks will provide a useful resource for future reference and analyses. Today's 
substances might be tomorrow's challenges.
The HBM conference illustrated the need to promote harmonized criteria, procedures and 
tools for the interpretation of HBM data and the enhancement of their use in human health 
risk assessment. Toxicological information required for developing these tools is becoming 
increasingly available through regulatory requirements such as those under the Registration, 
Evaluation, Authorization and Restriction of Chemicals (REACH) regulation and similar 
initiatives in other countries.
HBM provides scientific data to inform decision making by regulators, policy makers, and 
the general public. On the regulatory and policy side, HBM provides a mechanism for 
monitoring the success of policies in reducing exposure to environmental chemicals and for 
identifying areas for priority action. Approaches for communicating HBM results to the 
various users require further improvement.
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BMU and UBA, the organizers of the HBM conference, sincerely thank all authors and 
conference participants for their valuable contributions. We also want to gratefully 
recognize the work of the scientific committee for putting together an interesting programme 
and ensuring the high quality of the conference and the importance of its outcomes. Special 
thanks are due to the following additional members of the scientific committee:
Marika Berglund, Karolinska Institutet, Sweden; Argelia Castano, Instituto de Salud Carlos 
III, Spain; Birger Heinzow, State Office for Social Services, Germany; Holger Koch, 
Institute for Prevention and Occupational, Medicine, Germany; Greet Schoeters, Flemish 
Institute for Technological Research, Belgium; Yasuyuki Shibata, National Institute for 
Environmental Studies, Japan; and Ann-Catherine Viso, Institut de Veille Sanitaire, France.
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